Product Details
Qutenza 8% path, 4/box
Manufacturer: AVERITAS PHARMA INC
MFG#: 72512-0928-01
NDC: 72512-0928-01
PID: 417978
2/BX
$ *.**
Limited Quantities4/BX
$ *.**
Limited Quantities1/EA
$1,567.06
In StockAdditional Information
| Product Name | Qutenza 8% Patch, 4/Box |
| Application | TRPV1 Channel Agonist |
| Generic Drug Name | Capsaicin |
| Mechanism of Action | TRPV1 receptor desensitization to reduce pain signals |
| Strength | 8% (0.08) |
| Type | Topical |
| Volume | 50 Gram |
| Application Area | Intact, non-irritated skin |
| Duration of Use | Applied for up to 60 minutes |
| Warnings | Avoid contact with eyes, mucous membranes, and wounds |
| Handling Precautions | Use gloves to prevent exposure during application |
| Storage Requirements | Store at 20-25°C (68-77°F); protect from light |
| Packaging | Includes cleansing gel for capsaicin removal |
| Container Type | Single-Use Pouch |
| Use | Treats postherpetic neuralgia, diabetic neuropathy |
Description
Qutenza 8% Patch is a prescription topical system containing capsaicin, designed for single-use application. It is utilized for the treatment of neuropathic pain associated with conditions such as postherpetic neuralgia or diabetic peripheral neuropathy. Each carton includes one topical system and a 50-gram tube of cleansing gel, intended for use in post-treatment removal of residual capsaicin.
The patch measures 14 cm by 20 cm (280 cm²), with an adhesive layer that contains the active ingredient capsaicin, along with a clear, diagonally cut release liner for ease of application. The non-adhesive backing is marked with "Capsaicin 8%" for identification. Qutenza is specifically formulated to deliver high-concentration capsaicin directly to the skin, providing localized relief from pain by targeting overactive pain receptors.
The mechanism of action involves desensitization of TRPV1 receptors in the skin, effectively reducing pain signal transmission to the central nervous system. This targeted approach minimizes systemic absorption, offering a localized treatment option. The application is performed under medical supervision, ensuring precise placement and patient safety during the procedure.
Frequently Asked Questions (FAQs)
The cost of Qutenza 8% path, 4/box is $$0.00
Qutenza 8% path, 4/box is manufactured by AVERITAS PHARMA INC.
You can purchase Qutenza 8% path, 4/box on our website at https://injx.pipelinemedical.com/product/detail/qutenza-8-path-1-box-417977